Products, hold the platform

While many VCs are pumping record-breaking amounts of capital into big idea platform companies and urging them to fully explore their technologies, Clarus Ventures is sticking with its more measured approach.

In addition to keeping a tight focus on products via traditional venture investments in its newly closed third fund, the firm plans to deploy about half of the money in risk-sharing projects with pharma to develop late-stage assets. ...